Rule-Based High-Risk Flu
Part of paid clinical trials in Danville, Pennsylvania.
- Sponsor
- Geisinger Clinic
- Study ID
- NCT07798882
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Health Behavior
- Health Promotion
- Influenza
- Risk Reduction
- Vaccination
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Risk reduction — BEHAVIORALMailed letter, patient portal message and/or text message
Study Details
Previous work by the study team has shown that informing patients of their high risk of flu and flu-related complications increases their likelihood of getting a flu shot (Rosenbaum et al., 2026). In this work, an artificial intelligence (AI)-based algorithm determined which patients were at high risk for flu. This year, the team will test whether risk messages remain effective when a non-algorithmic rule-based additive risk index (McGovern et al., 2024) is used to identify patients at high risk.
Key Dates
- First listed
- Sep 2, 2026
- Start date
- Sep 1, 2026
- Status verified
- Aug 2026
- Primary completion
- Sep 30, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 51,215 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- No Intervention: ControlThis group will not be sent high-risk flu shot messages, but will be sent normal system messages about flu shots.
- Experimental: High-risk outreachThis group will be sent messages informing them of their high risk for flu and flu-related complications, in addition to the normal system messages sent to the control group.
Primary Outcome Measure
Flu vaccination (y/n) [ Time Frame: In the 29 days following the date the first messages were sent ]
Central Contacts
- Gail Rosenbaum, PhD570-243-1199
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Geisinger Health | Danville | Pennsylvania | 17822 | - |
Find similar trials in Danville, PA
Related Studies
- High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) RecipientsPHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Stanford, California
- A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household ContactsPHASE3 · Recruiting · Hoffmann-La Roche · Birmingham, Alabama
- Teaching Health Resilience in a Hospital Setting: A Peer-led InterventionRecruiting · University of Pennsylvania · Pittsburgh, Pennsylvania
- Screening for LID Clinical Studies Unit Healthy Volunteer ProtocolsRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland